Practice parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology

Category Structured summary of systematic reviews
JournalDatabase of Abstracts of Reviews of Effects (DARE)
Year 2008
Loading references information

CRD SUMMARY:

This review evaluated neuroprotective and non-standard therapies for patients with Parkinson disease. The authors concluded that disease progression does not appear to be increased by levadopa and no strategy provided neuroprotection. Although the authors' conclusions appear to be supported by the review, inadequate reporting of review methods and study details make it difficult to confirm the reliability of the conclusions.
Epistemonikos ID: 659ea6600a21e90bbf5259f9085fc84402eca526
First added on: Jun 07, 2012